Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

3 Reasons Why Pfizer Investors Will Win With a Consumer Business Sale or Spinoff
Motley Fool
Wed, 10/11/17 - 09:55 am
Tags:
Pfizer, consumer health, M&A
Pfizer to explore potential sale, spinoff of consumer healthcare business
Marketwatch
Tue, 10/10/17 - 09:33 am
Tags:
Pfizer, consumer health, M&A
Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September
Fierce Pharma
Mon, 10/9/17 - 11:24 am
Tags:
Pfizer, Lyrica, AbbVie, Humira, drug ads, television ads
[video+transcript]Is This How Drugmakers Will Kill Biosimilars?
Motley Fool
Tue, 10/3/17 - 11:40 am
Tags:
biosimilars, Pfizer, JNJ, Inflectra, Remicade
Does Pfizer really want Bristol-Myers? Likely, says one analyst. What's it waiting for?
Fierce Pharma
Mon, 10/2/17 - 10:19 pm
Tags:
Pfizer, Bristol-Myers Squibb, M&A
Lilly steps up to rival Pfizer, Novartis with Verzenio breast cancer approval
Fierce Pharma
Thu, 09/28/17 - 06:24 pm
Tags:
Eli Lilly, Pfizer, Novartis, Verzenio, breast cancer, Ibrance, Kisqali
Pfizer is falling short in a competitive market, Johnson & Johnson says as it hits back at Remicade biosimilar suit
Fierce Pharma
Tue, 09/26/17 - 09:39 pm
Tags:
Pfizer, JNJ, Remicade, Inflectra, biosimilars
In A First, Pfizer Spins Out Biotech Firm With $103 Million In Funding
Forbes
Mon, 09/25/17 - 09:52 am
Tags:
Pfizer, biotech, spinoff, SpringWorks Therapeutics
Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst
Fierce Pharma
Thu, 09/21/17 - 10:18 pm
Tags:
Pfizer, Ibrance, breast cancer
Pfizer hits a snag in bid to jump-start Sutent's flagging kidney cancer sales
Fierce Pharma
Thu, 09/21/17 - 10:02 pm
Tags:
Pfizer, Sutent, kidney cancer
Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod
Yahoo/Reuters
Thu, 09/21/17 - 08:38 am
Tags:
Bavencio, Europe, Merck KGaA, Pfizer, Merkel cell carcinoma
This squabble between two big drugmakers could have major implications for the U.S. health care system
Marketwatch
Thu, 09/21/17 - 08:36 am
Tags:
JNJ, Pfizer, antitrust, biosimilars, Remicade, Inflectra
3 Ways AI Is Changing Medicine
Motley Fool
Thu, 09/21/17 - 08:30 am
Tags:
artificial intelligence, Gritstone Oncology, Alphabet, cancer immunotherapy, IBM Watson, Pfizer, Google Brain, diabetes, retinal blindness, HeartFlow, Verily
Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
Fierce Pharma
Wed, 09/20/17 - 11:08 pm
Tags:
Pfizer, GSK, Eli Lilly, emerging markets
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
First Word Pharma
Wed, 09/20/17 - 11:03 am
Tags:
Pfizer, JNJ, Janssen, Remicade, biosimilars, Inflectra
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
Wed, 09/20/17 - 09:05 am
Tags:
drug pricing, reimbursement, Remicade, biosimilars, Janssen, Inflectra, Pfizer, Renflexis, Merck
New PhIII data in hand, Pfizer, Astellas hustle ahead in bid to expand US market for Xtandi
Endpoints
Thu, 09/14/17 - 10:27 am
Tags:
Pfizer, Astellas, clinical trials, Xtandi, prostate cancer
Prevnar 13 among blockbusters industry watchers peg as tribal licensing candidates
Fierce Pharma
Tue, 09/12/17 - 09:47 pm
Tags:
Prevnar 13, vaccines, licensing, Pfizer
AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend
Fierce Pharma
Mon, 09/11/17 - 09:06 pm
Tags:
AbbVie, Pfizer, JNJ, drug ads, television ads
Allergan's Patent Loophole Could Be a Huge Gift for Pfizer
Motley Fool
Mon, 09/11/17 - 09:54 am
Tags:
Allergan, patents, Restasis, Pfizer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.